Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.38 +0.20 (+6.29%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insight Molecular Diagnostics (IMDX) Non-Current Assets (2015 - 2026)

Updated

Insight Molecular Diagnostics' Non-Current Assets was $8.9 million in Q2 2026, down 62.4% from $23.68 million a year earlier and down 10.2% from the prior quarter.

Analysis

Insight Molecular Diagnostics (IMDX) Non-Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Insight Molecular Diagnostics came in at $10.45 million, down 55.2% from FY2024.

  • Non-Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -25.7% (FY2020 to FY2025).
  • In earlier years, Non-Current Assets was $23.32 million in FY2024 (-63.7%), $64.19 million in FY2023 (-13.9%), $74.56 million in FY2022 (-38.1%) and $120.42 million in FY2021 (+160.7%).
  • The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q2 2019.
  • Compared with a year earlier, Non-Current Assets has declined for seven straight quarters, with an average decline of 53.8% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was Q3 2021 (growth of 163.6%); the worst was Q3 2025 (a decline of 65.5%).
  • Per Business Quant data, IMDX's Non-Current Assets in the three quarters before Q2 2026 was $9.91 million (Q1 2026), $10.45 million (Q4 2025) and $22.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 89.81 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 84.70 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 78.99 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 11.33 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 68.92 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 33.51 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 37.24 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 42.59 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 7.05 Bn
10 Insight Molecular Diagnostics 103.74 Mn 27.46 Mn 157,000.00 8.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.90 Mn
Mar 31, 2026 9.91 Mn
Dec 31, 2025 10.45 Mn
Sep 30, 2025 22.55 Mn
Jun 30, 2025 23.68 Mn
Mar 31, 2025 24.10 Mn
Dec 31, 2024 23.32 Mn
Sep 30, 2024 65.42 Mn
Jun 30, 2024 64.75 Mn
Mar 31, 2024 64.44 Mn
Dec 31, 2023 64.19 Mn
Sep 30, 2023 64.67 Mn
Jun 30, 2023 66.56 Mn
Mar 31, 2023 67.15 Mn
Dec 31, 2022 74.56 Mn
Sep 30, 2022 120.71 Mn
Jun 30, 2022 121.68 Mn
Mar 31, 2022 121.65 Mn
Dec 31, 2021 120.42 Mn
Sep 30, 2021 120.75 Mn
API Access

Insight Molecular Diagnostics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=IMDX&period=max&api_key=YOUR_API_KEY